Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Optimizing Adult Vaccination Ecosystem in India
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Vaccines India
    Evidence Based Safety Contextualization of JAK inhibitors in the Treatment of Moderate to Severe Atopic Dermatitis
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology China, France, Germany, Italy, Japan, Korea, Spain, USA
    Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple Myeloma
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology Spain
    Optimizing Clinical Care Delivery for Patients with Multiple Myeloma Receiving Bispecific Antibodies
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology All
    Enhancing HCP Education in Maternal Vaccination
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines Saudi Arabia
    Diagnosis and Treatment of Cancer Cachexia
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Evidence-Based Education on the Potential Impact of a Generic JAK Inhibitor on the Management of Rheumatologic Diseases
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    B-cell Maturation Antigen (BCMA) Bi-Specific Antibodies (BsAbs) in Relapsed/Refractory Multiple Myeloma (RRMM)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Education on Mechanism of Action of JAK3 and TEC Family Kinase Role in Alopecia Areata
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    2026 Hemophilia Fellowship – United States
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Rare Disease All
    Pediatric Pneumococcal Disease and Serotype Distribution: Surveillance Studies in Saudi Arabia
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines Saudi Arabia
    Optimising Ulcerative Colitis Care: Bridging Knowledge Gaps, Integrating Biomarker-Based Strategies, and Advancing Equity
    Release Date:
    Review Process: Expert Review Panel
    Education Inflammation & Immunology Australia
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Cardiac Transthyretin Amyloid (ATTR) Fellowship
    Release Date:
    Partner: International Society of Amyloidosis
    Review Process: Expert Review Panel
    Fellowship Rare Disease All
    Early Diagnosis of Invasive Fungal Infections(Europe, Australia, New Zealand, Korea and Japan)
    Release Date:
    Review Process: Pfizer Internal
    Research Hospital All
    Pfizer and RCNi – Providing Access to Learning Resources for Nurses in Emerging Markets Asia
    Release Date:
    Partner: RCNi
    Review Process: Expert Review Panel
    Education Support for the Professions Hong Kong, India, Indonesia, Malaysia, Pakistan, Philippines, Singapore, Taiwan, Thailand, Vietnam
    Improving Real-World Evidence & Data Generation Skills in Latin America
    Release Date:
    Review Process: Pfizer Internal
    Education Support for the Professions All
    Optimizing Venous Thromboembolism Management in Latin America
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Internal Medicine All
    Alopecia Areata, Atopic Dermatitis and Vitiligo (Global)
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology All
    Relapsed/Refractory Multiple Myeloma
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Antimicrobial Stewardship (AMS) Programs to Address Health Inequities in Resource Limited Settings
    Release Date:
    Partner: Global Bridges at Mayo Clinic
    Review Process: Expert Review Panel
    Quality Improvement Hospital All
    Increase HCP knowledge of Gene Therapy management
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease China
    Burden of Pneumococcal Disease - Analyzing Local Surveillance Data (Asia, Africa, Latin America, and Middle East)
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines All
    Pre-clinical & Translational Research in Multiple Myeloma
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology All
    Acute Lymphoblastic Leukemia Peer-to-Peer Education & Support
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA